Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 20 studies | 53% ± 23% | |
lung | 13 studies | 33% ± 13% | |
peripheral blood | 13 studies | 23% ± 8% | |
eye | 10 studies | 41% ± 18% | |
heart | 5 studies | 44% ± 14% | |
kidney | 5 studies | 35% ± 15% | |
liver | 5 studies | 38% ± 20% | |
intestine | 5 studies | 22% ± 7% | |
breast | 4 studies | 26% ± 10% | |
adipose | 4 studies | 46% ± 20% | |
pancreas | 3 studies | 40% ± 20% | |
lymph node | 3 studies | 19% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6042.48 | 1445 / 1445 | 100% | 31.83 | 183 / 183 |
brain | 100% | 5982.13 | 2637 / 2642 | 99% | 30.86 | 700 / 705 |
breast | 100% | 6735.28 | 459 / 459 | 99% | 39.83 | 1106 / 1118 |
lung | 100% | 5624.07 | 577 / 578 | 99% | 22.90 | 1140 / 1155 |
ovary | 100% | 7877.73 | 180 / 180 | 98% | 17.21 | 421 / 430 |
prostate | 100% | 5746.71 | 245 / 245 | 97% | 24.89 | 487 / 502 |
stomach | 100% | 4618.79 | 359 / 359 | 97% | 21.67 | 277 / 286 |
thymus | 100% | 6559.44 | 653 / 653 | 96% | 22.68 | 583 / 605 |
pancreas | 99% | 3014.15 | 325 / 328 | 96% | 18.12 | 171 / 178 |
intestine | 100% | 6699.26 | 966 / 966 | 95% | 16.71 | 500 / 527 |
skin | 100% | 6863.86 | 1809 / 1809 | 94% | 20.44 | 444 / 472 |
uterus | 100% | 7336.95 | 170 / 170 | 93% | 17.94 | 429 / 459 |
bladder | 100% | 7011.62 | 21 / 21 | 93% | 14.85 | 467 / 504 |
kidney | 100% | 3433.07 | 89 / 89 | 90% | 16.88 | 808 / 901 |
adrenal gland | 100% | 5070.18 | 258 / 258 | 90% | 14.95 | 206 / 230 |
liver | 98% | 1861.60 | 222 / 226 | 70% | 9.29 | 283 / 406 |
adipose | 100% | 6241.48 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7700.68 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 7134.19 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3935.54 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 95% | 3834.49 | 815 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 18.25 | 42 / 45 |
eye | 0% | 0 | 0 / 0 | 81% | 9.93 | 65 / 80 |
peripheral blood | 69% | 2165.67 | 643 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 59% | 7.45 | 17 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0006954 | Biological process | inflammatory response |
GO_0009791 | Biological process | post-embryonic development |
GO_0032259 | Biological process | methylation |
GO_0000165 | Biological process | MAPK cascade |
GO_0046697 | Biological process | decidualization |
GO_0061038 | Biological process | uterus morphogenesis |
GO_0002674 | Biological process | negative regulation of acute inflammatory response |
GO_1903699 | Biological process | tarsal gland development |
GO_0006338 | Biological process | chromatin remodeling |
GO_1903709 | Biological process | uterine gland development |
GO_0030317 | Biological process | flagellated sperm motility |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0043409 | Biological process | negative regulation of MAPK cascade |
GO_0001501 | Biological process | skeletal system development |
GO_0007338 | Biological process | single fertilization |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005923 | Cellular component | bicellular tight junction |
GO_0005694 | Cellular component | chromosome |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0042800 | Molecular function | histone H3K4 methyltransferase activity |
GO_0140955 | Molecular function | histone H3K36 trimethyltransferase activity |
GO_0003682 | Molecular function | chromatin binding |
GO_0046974 | Molecular function | histone H3K9 methyltransferase activity |
GO_0140947 | Molecular function | histone H3K9me2 methyltransferase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0140938 | Molecular function | histone H3 methyltransferase activity |
GO_0046975 | Molecular function | histone H3K36 methyltransferase activity |
GO_0140948 | Molecular function | histone H3K9 monomethyltransferase activity |
Gene name | ASH1L |
Protein name | Histone-lysine N-methyltransferase ASH1L (EC 2.1.1.359) (EC 2.1.1.367) (ASH1-like protein) (huASH1) (Absent small and homeotic disks protein 1 homolog) (Lysine N-methyltransferase 2H) ASH1 like histone lysine methyltransferase |
Synonyms | KIAA1420 KMT2H |
Description | FUNCTION: Histone methyltransferase specifically trimethylating 'Lys-36' of histone H3 forming H3K36me3 . Also monomethylates 'Lys-9' of histone H3 (H3K9me1) in vitro (By similarity). The physiological significance of the H3K9me1 activity is unclear (By similarity). . |
Accessions | ENST00000676814.1 F8VWK7 ENST00000678699.1 A0A7I2V542 A0A7I2V4H9 H0YI82 ENST00000392403.8 [Q9NR48-2] ENST00000677992.1 ENST00000677042.1 ENST00000679097.1 [Q9NR48-2] A0A7I2V3D6 ENST00000492987.2 A0A7I2YQU9 A0A7I2V4K0 ENST00000679133.1 A0A7I2V316 ENST00000368346.7 [Q9NR48-1] ENST00000678117.1 [Q9NR48-2] ENST00000677825.1 ENST00000677213.1 [Q9NR48-2] ENST00000679333.1 A0A7I2YQL4 ENST00000548830.2 Q9NR48 |